On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...